Search results :

Tamsulosin

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: G04CA02

Side effects

Options: Hide MedDRA Preferred Terms ,   display all 37 labels

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Headache Headache postmarketing — 0.4% - 21.1% 0.6% - 20.1% x x x x x x x x x x x x x x x x x x
Dizziness Dizziness postmarketing — 1.3% - 17.1% 0.9% - 17.1% x x x x x x x x x x x x x x x x x x x x
Syncope postmarketing, rare x x x x x x x x x x x x x x x x x x x
Lightheadedness x x x x x x x x x x x x x x
Dizziness aggravated x
Dizzy spells x
Rhinitis Rhinitis postmarketing — 11.6% - 17.9% 6.9% - 17.9% x x x x x x x x x x x x x x x x x
Common cold x x
Infection Infection 4.51% - 10.8% 4.49% - 7.51% x x x x x x x x x x x x x x x x x
Ejaculation disorder Abnormal ejaculation postmarketing, 0.6% - 18.1% 0% - 18.1% x x x x x x x x x x x x x x x x x x x x
Ejaculation disorder common x x x x x x x x x x x x x x x x x x x
Asthenia Asthenia postmarketing — 0.7% - 8.54% 0.6% - 8.54% x x x x x x x x x x x x x x x x x x
Fatigue x
Pain Pain 7.6% 7.3% x x
Back pain Back pain 6.2% - 8.33% 4.5% - 8.33% x x x x x x x x x x x x x x x x
Diarrhoea Diarrhoea postmarketing — 4.27% - 6.2% 4.27% - 4.46% x x x x x x x x x x x x x x x x x
Pharyngitis Pharyngitis 4.3% - 5.8% 3.9% - 5.08% x x x x x x x x x x x x x x x x
Infestation Infestation NOS 4.51% - 5.56% 4.49% x
Gastrointestinal disorder Gastrointestinal disorder 3.89% - 4.8% 1.97% x x
Reaction gastrointestinal postmarketing x
Chest pain Chest pain 0.5% - 4.07% 0.3% - 4.07% x x x x x x x x x x x x x x x x
Dyspepsia Dyspepsia 3.8% 5.4% x x
Breast disorder Breast disorder 3.33% - 3.95% 0.562% x x
Nervous system disorder Nervous system disorder 3.06% - 4.09% 2.53% x x
Abdominal pain Abdominal pain 3.4% 4.3% x x
Gastrointestinal pain Abdominal pain 3.4% 4.3% x x
Cough Cough increased 3.1% - 4.47% 2.4% - 4.47% x x x x x x x x x x x x x x x x
Cough x x
Arthralgia Arthralgia 3% 3.3% x x
Musculoskeletal discomfort Arthralgia 3% 3.3% x x
Myalgia 1.7% 2.1% x
Somnolence Somnolence 2.5% - 4.27% 1.5% - 4.27% x x x x x x x x x x x x x x x x x
Mediastinal disorder Mediastinal disorder postmarketing, 2.78% - 2.82% 0.843% x x
Nausea Nausea postmarketing — 2.59% - 3.86% 2.9% - 3.86% x x x x x x x x x x x x x x x x x
Insomnia Insomnia 1.42% - 2.4% 0.6% - 1.42% x x x x x x x x x x x x x x x x
Cardiac disorder Cardiac disorder 2.22% - 2.26% 2.25% x x
Sinusitis Sinusitis 2.1% - 3.66% 1.3% - 3.66% x x x x x x x x x x x x x x x x
Angiopathy Angiopathy 2.12% 2.25% x x
Influenza Influenza 2.1% 2.9% x x
Injury Accidental injury 2.1% 3% x x
Connective tissue disorder Connective tissue disorder 1.69% - 2.5% 1.97% x
Myalgia Myalgia 1.7% 2.1% x
Urinary tract infection Urinary tract infection 1.5% 0.4% x x
Dysuria Dysuria 1.2% 1.3% x x
Erectile dysfunction Erectile dysfunction 1.2% 1.5% x x
Tooth disorder Tooth disorder 1.1% - 2.03% 0.9% - 2.03% x x x x x x x x x x x x x x x x
Arthritis Arthritis 1.1% 1% x x
Lung disorder Lung disorder 1.1% 0.9% x x
Hypertonia Hypertonia 1.1% 1.5% x x
Hyperhidrosis Sweating 1.1% 0.8% x x
Neck pain Neck pain 1% 1.1% x x
Body temperature increased Body temperature increased 1% 1% x
Fever chills x
Libido decreased Libido decreased 0.996% - 2.03% 0.9% - 2.03% x x x x x x x x x x x x x x x x
Disturbance in sexual arousal Libido decreased 0.996% - 2.03% 0.9% - 2.03% x x x x x x x x x x x x x x x x
Hypertension Hypertension 0.9% 1.1% x x
Oedema peripheral Oedema peripheral 0.8% 1% x x
Chills Chills 0.7% 1% x
Congenital genitourinary abnormality Congenital genitourinary abnormality 0.6% 0% x x
Paraesthesia Paraesthesia 0.4% 1.1% x x
Malaise Malaise 0.4% 1.1% x x
Discomfort Malaise 0.4% 1.1% x x
Feeling abnormal Malaise 0.4% 1.1% x x
Ill-defined disorder Malaise 0.4% 1.1% x x
Orthostatic hypotension Orthostatic hypotension postmarketing, uncommon x x x x x x x x x x x x x x x x x x x x
Hypotension orthostatic symptomatic x x x x x x x x x x x x x x x x
Vision blurred Vision blurred postmarketing, 0.199% - 2.03% 0.406% - 2.03% x x x x x x x x x x x x x x
Angioedema Angioedema postmarketing, rare x x x x x x x x x x x x x x x x x x x
Arrhythmia Arrhythmia postmarketing x x x x x x x x x x
Atrial fibrillation Atrial fibrillation postmarketing x x x x x x x x x x
Constipation Constipation postmarketing — 1.3% 1.4% x x x x x x x x x x x x x x x x x x x
Dermatitis exfoliative Dermatitis exfoliative postmarketing x x
Dyspnoea Dyspnoea postmarketing, 1.1% 1.1% x x x x x x x x x x x x
Epistaxis Epistaxis postmarketing x x
Erythema multiforme Erythema multiforme postmarketing x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x
Dermatitis Rash postmarketing — 1.8% 1.8% x x x x x x x x x x x x x x x x x x x
Rash Rash postmarketing — 1.8% 1.8% x x x x x x x x x x x x x x x x x x x
Hypersensitivity Hypersensitivity postmarketing x
Hypotension Hypotension postmarketing x x x x x x x x x x x x x x x x x
Miosis Miosis postmarketing x x x x x x x x x x x x x x x x x x x
Palpitations Palpitations postmarketing, uncommon x x x x x x x x x x x x x x x x x x x x
Priapism Priapism very rare, postmarketing x x x x x x x x x x x x x x x x x x x
Pruritus Pruritus postmarketing — 1% 1% x x x x x x x x x x x x x x x x x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x x x x x x x x x
Shock Syncope postmarketing, rare x x x x x x x x x x x x x x x x x x x
Shock x
Syncope Syncope postmarketing, rare x x x x x x x x x x x x x x x x x x x
Loss of consciousness Syncope postmarketing, rare x x x x x x x x x x x x x x x x x x x
Loss of consciousness
Tachycardia Tachycardia postmarketing x x x x x x x x x x x x x x x
Urticaria Urticaria postmarketing, uncommon x x x x x x x x x x x x x x x x x x x
Visual impairment Disorder sight postmarketing
Visual impairment postmarketing x x
Vomiting Vomiting postmarketing, uncommon x x x x x x x x x x x x x x x x x x x
Cataract Cataract postmarketing x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x
Skin exfoliation Skin exfoliation postmarketing x x x x x x x x x x x x x x x x
Floppy iris syndrome Intraoperative floppy iris syndrome postmarketing x x x x x x x x x x x x x x x x x x x
Amblyopia Amblyopia x x
Nasopharyngitis Common cold x x
Rhinorrhoea x x
Fatigue Fatigue x
Seasonal allergy Seasonal allergy x x
Rhinitis seasonal Seasonal allergy x x
Nasal congestion Nasal congestion x x x
Nasal obstruction Nasal obstruction x
Vertigo Vertigo x x x x x x x x x x x x x x x x
Sinus congestion Sinus congestion x x
Malnutrition Malnutrition x x
Ejaculation delayed Ejaculation delayed x
Dizziness postural Dizziness postural x
Blood pressure systolic decreased Blood pressure systolic decreased x x x x x x x x x x x x x x x x
Blood pressure diastolic decreased Blood pressure diastolic decreased x x x x x x x x x x x x x x
Ejaculation failure Ejaculation failure x x x x x x x x x x x x x x x x x x x
Influenza like illness Influenza-like symptoms x x
Retrograde ejaculation Retrograde ejaculation x x x x x x x x x x x x x x x x x x x
Drug interaction Drug interaction x x x x x x x x x x x x
Rhinorrhoea Rhinorrhoea x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

TAMSULOSIN

Side effects:23
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:29
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:41
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:42
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:42
Source:FDA Structured Product Label

TAMSULOSIN HYDROCHLORIDE / FLOMAX CR

Side effects:43
Source:Health Canada

TAMSULOSIN

Side effects:46
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:46
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:46
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:46
Source:FDA Structured Product Label

Tamsulosin

Side effects:46
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:46
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:46
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:47
Source:FDA Structured Product Label

TAMSULOSIN HYDROCHLORIDE / FLOMAX

Side effects:47
Source:FDA

tamsulosin

Side effects:51
Source:FDA Structured Product Label

TAMSULOSIN

Side effects:51
Source:FDA Structured Product Label

TAMSULOSIN HYDROCHLORIDE / NOVO-TAMSULOSIN

Side effects:57
Source:Health Canada

TAMSULOSIN HYDROCHLORIDE / FLOMAX

Side effects:63
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label